We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Breakthrough Brain PET System Aids Diagnosis of Neurological Disorders

By MedImaging International staff writers
Posted on 17 Jul 2024
Print article
Image: The NeuroLF ultra-compact brain Positron Emission Tomography (PET) scanner (Photo courtesy of Positrigo)
Image: The NeuroLF ultra-compact brain Positron Emission Tomography (PET) scanner (Photo courtesy of Positrigo)

Alzheimer's disease (AD) is the most prevalent type of dementia, representing approximately 70% of all dementia cases in individuals over 60 years of age. As of 2020, there were more than 55 million people globally living with dementia, and this number is expected to rise to 139 million by 2050. Early diagnosis is crucial, and Positron Emission Tomography (PET) imaging plays a key role in the accurate diagnosis of AD. However, conventional PET scanners, which are typically large and integrated with MRI or CT technologies, are expensive to purchase and maintain and require considerable space, limiting their accessibility. Now, an ultra-compact dedicated brain PET scanner can assist in diagnosing and monitoring brain-related disorders like AD, brain tumors, epilepsy, Parkinson’s disease, and others.

Positrigo’s (Zurich, Switzerland) NeuroLF brain PET system marks a significant shift in medical imaging by offering a device dedicated to imaging a specific body part or organ, similar to what is done in cardiac imaging. This innovation in brain imaging technology leverages advances in mechanical, electronic, and software engineering to create a system that occupies minimal space and does not require special room modifications. The NeuroLF allows patients to undergo brain scans in a seated position, facilitating functional imaging directly at the point of care.

Positrigo has received clearance from the U.S. Food and Drug Administration (FDA) for the NeuroLF, with approval in the European market anticipated later this year. The timing of the launch of a dedicated brain PET device aligns well with recent advancements in Alzheimer’s treatment, including the FDA approval earlier this month of another disease-modifying therapy for AD—the third such medication approved in the US following two others last year. This FDA clearance for Positrigo's first product positions the company closer to achieving its mission of imaging everyone.

“It is not the first device of its kind which receives market clearance in the US but we believe that our patient-centric and customer-driven design and development efforts over the last couple of years, brought us into the pole position to offer the best imaging solution to address the increased demand of brain PET scans,” says Dr. Jannis Fischer, co-founder and CEO.

Related Links:
Positrigo

New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Opaque X-Ray Mobile Lead Barrier
2594M
New
Mammography Analytics Platform
Unifi Analytics Software
New
Gold Member
X-Ray QA Meter
T3 RG Pro

Print article
Radcal

Channels

Radiography

view channel
Image: The CT scanner prototype eliminates the need for physical compression of the breast (Photo courtesy of Quion Lowe and Lisa Dahm/U of A Cancer Center)

Novel Breast Cancer Screening Technology Could Offer Superior Alternative to Mammogram

Breast cancer represents 15.5% of new cancer cases and 7% of cancer-related deaths in the United States. Approximately 13.1% of women will be diagnosed with breast cancer during their lifetime.... Read more

Ultrasound

view channel
Image: Wearable ultrasound device offers continuous, long-term monitoring of muscle activity (Photo courtesy of Muyang Lin/UC San Diego)

Wearable Ultrasound Device Provides Long-Term, Wireless Muscle Monitoring

Electromyography (EMG) is the current clinical standard for monitoring muscle activity, utilizing metal electrodes placed on the skin to capture electrical signals from muscles. Despite its long-standing... Read more

Nuclear Medicine

view channel
Image: PET scans of a glioblastoma patient\'s brain, 72 hours after injection with the radiotracer (Photo courtesy of Dr Gabriela Kramer-Marek, The Institute of Cancer Research, London)

New Immuno-PET Imaging Technique Identifies Glioblastoma Patients Who Would Benefit from Immunotherapy

Glioblastoma is a type of brain tumor associated with a very poor prognosis, with average survival rates of 12 to 18 months and only 5% of patients surviving beyond five years. Research has shown that... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The advocacy partnership aims to help accelerate access to life-saving treatments (Photo courtesy of Philips)

Philips and Medtronic Partner on Stroke Care

A stroke is typically an acute incident primarily caused by a blockage in a brain blood vessel, which disrupts the adequate blood supply to brain tissue and results in the permanent loss of brain cells.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.